Market Tracker

02/20 12:30pm ET

United Therapeutics Corp (NASDAQ:UTHR)

168.16
Delayed Data
As of Feb 17
 -0.26 / -0.15%
Today’s Change
97.52
Today|||52-Week Range
168.82
+17.24%
Year-to-Date

Today’s Trading

Previous close168.42
Today’s open167.06
Day’s range166.13 - 168.64
Volume324,190
Average volume (3 months)581,376
Market cap$7.1B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+28.36%
Earnings growth (next 5 years)+16.65%
Revenue growth (last year)+13.76%
P/E ratio11.3
Price/Sales5.47
Price/Book4.84

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.12-0.28%
JAZZJazz Pharmaceuticals...+0.78+0.57%
ALKSAlkermes Plc-0.98-1.76%
MNKMallinckrodt Plc+2.24+4.27%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$3.56
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts